Clinical Trial Detail

NCT ID NCT02655016
Title A Study of Niraparib Maintenance Treatment in Patients With HRD-Positive Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy
Recruitment Active, not recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors Tesaro, Inc.
Indications

fallopian tube cancer

peritoneum cancer

ovarian cancer

Therapies

Niraparib

Age Groups: adult

No variant requirements are available.